GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Days Payable

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Days Payable : 65.04 (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Payable?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's average Accounts Payable for the three months ended in Mar. 2024 was HK$8.4 Mil. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was HK$11.8 Mil. Hence, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable for the three months ended in Mar. 2024 was 65.04.

The historical rank and industry rank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable or its related term are showing as below:

HKSE:01349' s Days Payable Range Over the Past 10 Years
Min: 26.21   Med: 32.57   Max: 58.48
Current: 45.34

During the past 13 years, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's highest Days Payable was 58.48. The lowest was 26.21. And the median was 32.57.

HKSE:01349's Days Payable is ranked worse than
77.74% of 975 companies
in the Drug Manufacturers industry
Industry Median: 87.13 vs HKSE:01349: 45.34

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable increased from Mar. 2023 (38.33) to Mar. 2024 (65.04). It may suggest that Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co delayed paying its suppliers.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Payable Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Payable Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.12 32.88 29.91 35.57 40.42

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.33 33.33 56.69 45.22 65.04

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable falls into.



Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (8.298 + 8.81) / 2 ) / 77.252*365
=8.554 / 77.252*365
=40.42

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (8.81 + 8.029) / 2 ) / 11.813*365 / 4
=8.4195 / 11.813*365 / 4
=65.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Payable Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Traded in Other Exchanges
Address
No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines